Lexaria Bioscience (LEXX) Shareholder's Equity (2010 - 2026)
Lexaria Bioscience (LEXX) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
6.60 Mn |
| Date | Value |
|---|
| Feb 28, 2026 |
6.60 Mn |
| Nov 30, 2025 |
4.52 Mn |
| Aug 31, 2025 |
2.99 Mn |
| May 31, 2025 |
5.17 Mn |
| Feb 28, 2025 |
6.76 Mn |
| Nov 30, 2024 |
9.39 Mn |
| Aug 31, 2024 |
7.66 Mn |
| May 31, 2024 |
9.75 Mn |
| Feb 29, 2024 |
6.15 Mn |
| Nov 30, 2023 |
3.37 Mn |
| Aug 31, 2023 |
2.68 Mn |
| May 31, 2023 |
4.04 Mn |
| Feb 28, 2023 |
4.63 Mn |
| Nov 30, 2022 |
5.93 Mn |
| Aug 31, 2022 |
7.63 Mn |
| May 31, 2022 |
8.91 Mn |
| Feb 28, 2022 |
11.22 Mn |
| Nov 30, 2021 |
11.47 Mn |
| Aug 31, 2021 |
13.06 Mn |
| May 31, 2021 |
10.27 Mn |
